# agilon health, inc. (AGL) Stock Analysis: Exploring the 95% Potential Upside

- Link: https://www.directorstalkinterviews.com/agilon-health-inc-agl-stock-analysis-exploring-the-95-potential-upside/4121202791
- Published: 2025-06-17T10:46:50+01:00
- Author: Madison Wilson

For investors eyeing opportunities in the healthcare sector, agilon health, inc.(
NYSE: AGL) presents a compelling case, especially with a potential upside of 95.12%
as indicated by current analyst ratings. This article delves into the company’s 
financial standing and performance metrics to provide a clearer picture for individual
investors considering this stock.

**Company Overview**

Based in Westerville, Ohio, agilon health operates within the Medical Care Facilities
industry. The company focuses on providing healthcare services for seniors through
a network of primary care physicians across the United States. By leveraging a subscription-
based model, agilon health manages the comprehensive healthcare needs of its patients
on a per-member per-month basis, positioning itself as a significant player in the
evolving healthcare landscape.

**Current Market Position**

Currently trading at $2.18, agilon health’s stock has experienced a modest change
of $0.03, reflecting a 0.01% increase. The stock’s 52-week range spans from $1.57
to $7.52, suggesting significant volatility and potential for growth. With a market
capitalization of $902.42 million, agilon health is a relatively small-cap company
within the healthcare sector, which often attracts investors looking for high-growth
potential.

**Valuation and Financial Health**

When assessing agilon health’s valuation metrics, traditional figures like P/E and
PEG ratios are unavailable, which may present a challenge for value investors. However,
the forward P/E ratio stands at -9.89, indicating expectations of future losses.
The absence of other valuation metrics such as Price/Book and Price/Sales further
complicates a straightforward valuation analysis.

The company’s performance metrics reveal areas of concern, particularly with a revenue
growth decline of -4.50% and a negative EPS of -0.62. The return on equity is notably
low at -42.97%, signaling inefficiencies in generating profit from shareholders’
equity. Despite these challenges, agilon health maintains a positive free cash flow
of $1,115,125, highlighting its ability to cover operational expenses and possibly
invest in growth initiatives.

**Analyst Ratings and Potential Upside**

Investor sentiment appears cautiously optimistic, with 4 buy ratings, 14 hold ratings,
and 2 sell ratings from analysts. The target price range is between $1.00 and $7.50,
with an average target price of $4.25. This suggests a substantial potential upside
of 95.12%, appealing to investors who are willing to accept the inherent risks for
higher returns.

**Technical Indicators**

Examining technical indicators, agilon health’s 50-day moving average of $3.34 and
200-day moving average of $3.14 provide insights into the stock’s recent performance
trends. The Relative Strength Index (RSI) stands at 31.40, indicating the stock 
is nearing oversold territory, which could signal a buying opportunity for technical
traders. Additionally, the MACD of -0.28 and a signal line of -0.34 suggest a bearish
trend, warranting cautious optimism.

**Investor Considerations**

Investors considering agilon health should weigh the potential rewards against the
risks. The company’s innovative healthcare model and significant potential upside
offer enticing prospects. However, challenges such as negative revenue growth and
low return on equity should not be overlooked. For risk-tolerant investors, particularly
those seeking exposure to the healthcare sector’s transformational dynamics, agilon
health, inc. could be a stock to watch closely.

Share on:
